Giulia Culletta

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Combined In Silico Approaches for Virtual Screening of Noncovalent Immunoproteasome Inhibitors for Multiple Myeloma Treatment.

Combined In Silico Approaches for Virtual Screening of Noncovalent Immunoproteasome Inhibitors for Multiple Myeloma Treatment.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 07, 2026

QSAR-Guided Design of Serotonin Transporter Inhibitors Supported by Molecular Docking and Biased Molecular Dynamics.

QSAR-Guided Design of Serotonin Transporter Inhibitors Supported by Molecular Docking and Biased Molecular Dynamics.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 07, 2026

Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug design.

Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug design.

Journal: Scientific reports

Published: November 10, 2025

Docking in the Dark: Insights into Protein-Protein and Protein-Ligand Blind Docking.

Docking in the Dark: Insights into Protein-Protein and Protein-Ligand Blind Docking.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 29, 2025

Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation.

Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation.

Journal: Molecular genetics and metabolism

Published: April 15, 2025

In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors.

In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors.

Journal: Journal of molecular graphics & modelling

Published: February 13, 2025

Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis.

Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis.

Journal: European journal of medicinal chemistry

Published: June 28, 2024

CDK2 Allosteric Modulators: The New Route in the Design of New Drugs as Anticancer and Non-hormonal Contraceptives.

CDK2 Allosteric Modulators: The New Route in the Design of New Drugs as Anticancer and Non-hormonal Contraceptives.

Journal: Current medicinal chemistry

Published: June 03, 2024

Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects.

Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects.

Journal: European journal of medicinal chemistry

Published: January 16, 2024

Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome.

Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome.

Journal: International journal of molecular sciences

Published: April 26, 2023

Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR.

Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR.

Journal: International journal of molecular sciences

Published: April 18, 2023

Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors.

Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: December 06, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026